Antisense & RNAi Therapeutics Market Report

Global and China Antisense & RNAi Therapeutics Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 05, 2022
  • PAGES：199
  • REPORT CODE：GMM1347833
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Antisense & RNAi Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Arbutus Biopharma (formerly known as Tekmira Pharmaceuticals)

    • Lorus Therapeutics (Aptose Biosciences)

    • iCo Therapeutics

    • Ionis Pharmaceuticals

    • Calando Pharmaceuticals (Arrowhead Pharmaceuticals, Inc)

    • Acuitas Therapeutics

    • Benitec Biopharma

    • Olix Pharmaceuticals

    • Antisense Therapeutics Ltd

    • Sanofi-Genzyme

    • Gene Signal

    • miRagen Therapeutics

    • Rexahn Pharmaceuticals

    • GlaxoSmithKline Plc

    • Enzon Pharmaceuticals Inc

    • Marina Biosciences

    • Silence Therapeutics Plc

    • Mirna Therapeutics Inc

    • Gradalis

    • Alnylam Pharmaceuticals

    • Bio-Path Holdings Inc

    • OncoGeneX Pharmaceuticals

    • Quark Pharmaceuticals

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • RNA Interference

    • SiRNA

    • MiRNA

    • Antisense RNA

    Application:

    • Oncology

    • Cardiovascular

    • Renal

    • Neurodegenerative

    • Respiratory

    • Genetic

    • Infectious Diseases

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Antisense & RNAi Therapeutics Industry Overview

      • 1.1.1 Antisense & RNAi Therapeutics Market Scope and Market Segments

      • 1.1.2 Antisense & RNAi Therapeutics Industry Characteristics

      • 1.1.3 Global and China Antisense & RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Antisense & RNAi Therapeutics Production Value and Growth Rate (2017-2028)

    • 1.2 Global Antisense & RNAi Therapeutics Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 RNA Interference

      • 1.2.2 SiRNA

      • 1.2.3 MiRNA

      • 1.2.4 Antisense RNA

    • 1.3 Global Antisense & RNAi Therapeutics Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Oncology

      • 1.3.2 Cardiovascular

      • 1.3.3 Renal

      • 1.3.4 Neurodegenerative

      • 1.3.5 Respiratory

      • 1.3.6 Genetic

      • 1.3.7 Infectious Diseases

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Antisense & RNAi Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Antisense & RNAi Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Antisense & RNAi Therapeutics Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Antisense & RNAi Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Antisense & RNAi Therapeutics Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Antisense & RNAi Therapeutics Industry Porter's Five Forces Model Analysis

      • 2.2.3 Antisense & RNAi Therapeutics Industry PEST Analysis

    • 2.3 Antisense & RNAi Therapeutics Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Antisense & RNAi Therapeutics Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Antisense & RNAi Therapeutics Industry

    Chapter 3 Global and China Antisense & RNAi Therapeutics Market, by Manufacturer

    • 3.1 Global and China Antisense & RNAi Therapeutics Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Antisense & RNAi Therapeutics Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Antisense & RNAi Therapeutics Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Antisense & RNAi Therapeutics Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Antisense & RNAi Therapeutics Market Top 3 Players

    Chapter 4 Global and China Antisense & RNAi Therapeutics Market, by Type (2017-2028)

    • 4.1 Antisense & RNAi Therapeutics Market Trend, by Type

    • 4.2 Global Antisense & RNAi Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Antisense & RNAi Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Antisense & RNAi Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Antisense & RNAi Therapeutics Price Trend, by Type (2017-2028)

    • 4.3 China Antisense & RNAi Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Antisense & RNAi Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Antisense & RNAi Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Antisense & RNAi Therapeutics Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Antisense & RNAi Therapeutics Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Antisense & RNAi Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Antisense & RNAi Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Antisense & RNAi Therapeutics Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Antisense & RNAi Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Antisense & RNAi Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Antisense & RNAi Therapeutics Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Antisense & RNAi Therapeutics Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Antisense & RNAi Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Antisense & RNAi Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Antisense & RNAi Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Antisense & RNAi Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Antisense & RNAi Therapeutics Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Antisense & RNAi Therapeutics Market Analysis

    • 7.1 North America Antisense & RNAi Therapeutics Market, by Type

    • 7.2 North America Antisense & RNAi Therapeutics Market, by Application

    • 7.3 North America Antisense & RNAi Therapeutics Market Analysis and Forecast, by Country

      • 7.3.1 United States Antisense & RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Antisense & RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Antisense & RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Antisense & RNAi Therapeutics Market Analysis

    • 8.1 Europe Antisense & RNAi Therapeutics Market, by Type

    • 8.2 Europe Antisense & RNAi Therapeutics Market, by Application

    • 8.3 Europe Antisense & RNAi Therapeutics Market Analysis and Forecast, by Country

      • 8.3.1 Germany Antisense & RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Antisense & RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Antisense & RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Antisense & RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Antisense & RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Antisense & RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Antisense & RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Antisense & RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Antisense & RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Antisense & RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Antisense & RNAi Therapeutics Market Analysis

    • 9.1 APAC Antisense & RNAi Therapeutics Market, by Type

    • 9.2 APAC Antisense & RNAi Therapeutics Market, by Application

    • 9.3 APAC Antisense & RNAi Therapeutics Market Analysis and Forecast, by Country

      • 9.3.1 China Antisense & RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Antisense & RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Antisense & RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Antisense & RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Antisense & RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Antisense & RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Antisense & RNAi Therapeutics Market Analysis

    • 10.1 Latin America, Middle East and Africa Antisense & RNAi Therapeutics Market, by Type

    • 10.2 Latin America, Middle East and Africa Antisense & RNAi Therapeutics Market, by Application

    • 10.3 Latin America, Middle East and Africa Antisense & RNAi Therapeutics Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Antisense & RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Antisense & RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Antisense & RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Antisense & RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Antisense & RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Antisense & RNAi Therapeutics Company Profiles

      • 11.1 Arbutus Biopharma (formerly known as Tekmira Pharmaceuticals)

        • 11.1.1 Arbutus Biopharma (formerly known as Tekmira Pharmaceuticals) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Arbutus Biopharma (formerly known as Tekmira Pharmaceuticals) Antisense & RNAi Therapeutics Product Profiles, Application and Specification

        • 11.1.3 Arbutus Biopharma (formerly known as Tekmira Pharmaceuticals) Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Lorus Therapeutics (Aptose Biosciences)

        • 11.2.1 Lorus Therapeutics (Aptose Biosciences) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Lorus Therapeutics (Aptose Biosciences) Antisense & RNAi Therapeutics Product Profiles, Application and Specification

        • 11.2.3 Lorus Therapeutics (Aptose Biosciences) Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 iCo Therapeutics

        • 11.3.1 iCo Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 iCo Therapeutics Antisense & RNAi Therapeutics Product Profiles, Application and Specification

        • 11.3.3 iCo Therapeutics Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Ionis Pharmaceuticals

        • 11.4.1 Ionis Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Ionis Pharmaceuticals Antisense & RNAi Therapeutics Product Profiles, Application and Specification

        • 11.4.3 Ionis Pharmaceuticals Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Calando Pharmaceuticals (Arrowhead Pharmaceuticals, Inc)

        • 11.5.1 Calando Pharmaceuticals (Arrowhead Pharmaceuticals, Inc) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Calando Pharmaceuticals (Arrowhead Pharmaceuticals, Inc) Antisense & RNAi Therapeutics Product Profiles, Application and Specification

        • 11.5.3 Calando Pharmaceuticals (Arrowhead Pharmaceuticals, Inc) Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Acuitas Therapeutics

        • 11.6.1 Acuitas Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Acuitas Therapeutics Antisense & RNAi Therapeutics Product Profiles, Application and Specification

        • 11.6.3 Acuitas Therapeutics Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Benitec Biopharma

        • 11.7.1 Benitec Biopharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Benitec Biopharma Antisense & RNAi Therapeutics Product Profiles, Application and Specification

        • 11.7.3 Benitec Biopharma Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Olix Pharmaceuticals

        • 11.8.1 Olix Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Olix Pharmaceuticals Antisense & RNAi Therapeutics Product Profiles, Application and Specification

        • 11.8.3 Olix Pharmaceuticals Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Antisense Therapeutics Ltd

        • 11.9.1 Antisense Therapeutics Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Antisense Therapeutics Ltd Antisense & RNAi Therapeutics Product Profiles, Application and Specification

        • 11.9.3 Antisense Therapeutics Ltd Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Sanofi-Genzyme

        • 11.10.1 Sanofi-Genzyme Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Sanofi-Genzyme Antisense & RNAi Therapeutics Product Profiles, Application and Specification

        • 11.10.3 Sanofi-Genzyme Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Gene Signal

        • 11.11.1 Gene Signal Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Gene Signal Antisense & RNAi Therapeutics Product Profiles, Application and Specification

        • 11.11.3 Gene Signal Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 miRagen Therapeutics

        • 11.12.1 miRagen Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 miRagen Therapeutics Antisense & RNAi Therapeutics Product Profiles, Application and Specification

        • 11.12.3 miRagen Therapeutics Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Rexahn Pharmaceuticals

        • 11.13.1 Rexahn Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Rexahn Pharmaceuticals Antisense & RNAi Therapeutics Product Profiles, Application and Specification

        • 11.13.3 Rexahn Pharmaceuticals Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 GlaxoSmithKline Plc

        • 11.14.1 GlaxoSmithKline Plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 GlaxoSmithKline Plc Antisense & RNAi Therapeutics Product Profiles, Application and Specification

        • 11.14.3 GlaxoSmithKline Plc Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Enzon Pharmaceuticals Inc

        • 11.15.1 Enzon Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Enzon Pharmaceuticals Inc Antisense & RNAi Therapeutics Product Profiles, Application and Specification

        • 11.15.3 Enzon Pharmaceuticals Inc Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 Marina Biosciences

        • 11.16.1 Marina Biosciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 Marina Biosciences Antisense & RNAi Therapeutics Product Profiles, Application and Specification

        • 11.16.3 Marina Biosciences Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.17 Silence Therapeutics Plc

        • 11.17.1 Silence Therapeutics Plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.17.2 Silence Therapeutics Plc Antisense & RNAi Therapeutics Product Profiles, Application and Specification

        • 11.17.3 Silence Therapeutics Plc Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.18 Mirna Therapeutics Inc

        • 11.18.1 Mirna Therapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.18.2 Mirna Therapeutics Inc Antisense & RNAi Therapeutics Product Profiles, Application and Specification

        • 11.18.3 Mirna Therapeutics Inc Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.19 Gradalis

        • 11.19.1 Gradalis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.19.2 Gradalis Antisense & RNAi Therapeutics Product Profiles, Application and Specification

        • 11.19.3 Gradalis Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.20 Alnylam Pharmaceuticals

        • 11.20.1 Alnylam Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.20.2 Alnylam Pharmaceuticals Antisense & RNAi Therapeutics Product Profiles, Application and Specification

        • 11.20.3 Alnylam Pharmaceuticals Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.21 Bio-Path Holdings Inc

        • 11.21.1 Bio-Path Holdings Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.21.2 Bio-Path Holdings Inc Antisense & RNAi Therapeutics Product Profiles, Application and Specification

        • 11.21.3 Bio-Path Holdings Inc Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.22 OncoGeneX Pharmaceuticals

        • 11.22.1 OncoGeneX Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.22.2 OncoGeneX Pharmaceuticals Antisense & RNAi Therapeutics Product Profiles, Application and Specification

        • 11.22.3 OncoGeneX Pharmaceuticals Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.23 Quark Pharmaceuticals

        • 11.23.1 Quark Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.23.2 Quark Pharmaceuticals Antisense & RNAi Therapeutics Product Profiles, Application and Specification

        • 11.23.3 Quark Pharmaceuticals Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Antisense & RNAi Therapeutics Industry Investment Prospect and Risk Assessment

    • 12.1 Antisense & RNAi Therapeutics Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Antisense & RNAi Therapeutics Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Antisense & RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China Antisense & RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Global Antisense & RNAi Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure China Antisense & RNAi Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure Global Antisense & RNAi Therapeutics Market Size and Growth Rate of RNA Interference (2017-2028)

    • Figure Global Antisense & RNAi Therapeutics Market Size and Growth Rate of SiRNA (2017-2028)

    • Figure Global Antisense & RNAi Therapeutics Market Size and Growth Rate of MiRNA (2017-2028)

    • Figure Global Antisense & RNAi Therapeutics Market Size and Growth Rate of Antisense RNA (2017-2028)

    • Figure Global Antisense & RNAi Therapeutics Market Size and Growth Rate of Oncology (2017-2028)

    • Figure Global Antisense & RNAi Therapeutics Market Size and Growth Rate of Cardiovascular (2017-2028)

    • Figure Global Antisense & RNAi Therapeutics Market Size and Growth Rate of Renal (2017-2028)

    • Figure Global Antisense & RNAi Therapeutics Market Size and Growth Rate of Neurodegenerative (2017-2028)

    • Figure Global Antisense & RNAi Therapeutics Market Size and Growth Rate of Respiratory (2017-2028)

    • Figure Global Antisense & RNAi Therapeutics Market Size and Growth Rate of Genetic (2017-2028)

    • Figure Global Antisense & RNAi Therapeutics Market Size and Growth Rate of Infectious Diseases (2017-2028)

    • Figure North America Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Antisense & RNAi Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Antisense & RNAi Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Antisense & RNAi Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Antisense & RNAi Therapeutics Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Antisense & RNAi Therapeutics Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Antisense & RNAi Therapeutics Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Antisense & RNAi Therapeutics Market Share, by Manufacturer in 2021

    • Figure Global and China Antisense & RNAi Therapeutics Market Share, by Manufacturer in 2022

    • Table Global Antisense & RNAi Therapeutics Sales Volume, by Type (2017-2028)

    • Table Global Antisense & RNAi Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Global Antisense & RNAi Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Global Antisense & RNAi Therapeutics Sales Value, by Type (2017-2028)

    • Table Global Antisense & RNAi Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure Global Antisense & RNAi Therapeutics Price Trend, by Type (2017-2028)

    • Table China Antisense & RNAi Therapeutics Sales Volume, by Type (2017-2028)

    • Table China Antisense & RNAi Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure China Antisense & RNAi Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table China Antisense & RNAi Therapeutics Sales Value, by Type (2017-2028)

    • Table China Antisense & RNAi Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure China Antisense & RNAi Therapeutics Price Trend, by Type (2017-2028)

    • Table Global Antisense & RNAi Therapeutics Sales Volume, by Application (2017-2028)

    • Table Global Antisense & RNAi Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Global Antisense & RNAi Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table Global Antisense & RNAi Therapeutics Sales Value, by Application (2017-2028)

    • Table Global Antisense & RNAi Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure Global Antisense & RNAi Therapeutics Sales Value Share, by Application (2017-2028)

    • Table China Antisense & RNAi Therapeutics Sales Volume, by Application (2017-2028)

    • Table China Antisense & RNAi Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China Antisense & RNAi Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table China Antisense & RNAi Therapeutics Sales Value, by Application (2017-2028)

    • Table China Antisense & RNAi Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China Antisense & RNAi Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China Antisense & RNAi Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure North America Antisense & RNAi Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Antisense & RNAi Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Antisense & RNAi Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Antisense & RNAi Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Table North America Antisense & RNAi Therapeutics Sales Volume, by Type (2017-2028)

    • Table North America Antisense & RNAi Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure North America Antisense & RNAi Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table North America Antisense & RNAi Therapeutics Sales Volume, by Application (2017-2028)

    • Table North America Antisense & RNAi Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure North America Antisense & RNAi Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure United States Antisense & RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure United States Antisense & RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Canada Antisense & RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Antisense & RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Antisense & RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Antisense & RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Europe Antisense & RNAi Therapeutics Sales Volume, by Type (2017-2028)

    • Table Europe Antisense & RNAi Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Europe Antisense & RNAi Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Europe Antisense & RNAi Therapeutics Sales Volume, by Application (2017-2028)

    • Table Europe Antisense & RNAi Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Europe Antisense & RNAi Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Germany Antisense & RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Antisense & RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure UK Antisense & RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure UK Antisense & RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure France Antisense & RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure France Antisense & RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Italy Antisense & RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Antisense & RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Antisense & RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Antisense & RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Spain Antisense & RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Antisense & RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Antisense & RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Antisense & RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Poland Antisense & RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Antisense & RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Russia Antisense & RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Antisense & RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Antisense & RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Antisense & RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table APAC Antisense & RNAi Therapeutics Sales Volume, by Type (2017-2028)

    • Table APAC Antisense & RNAi Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure APAC Antisense & RNAi Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table APAC Antisense & RNAi Therapeutics Sales Volume, by Application (2017-2028)

    • Table APAC Antisense & RNAi Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure APAC Antisense & RNAi Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China Antisense & RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China Antisense & RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Japan Antisense & RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Antisense & RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Antisense & RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Antisense & RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure India Antisense & RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure India Antisense & RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Antisense & RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Antisense & RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Antisense & RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Antisense & RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Antisense & RNAi Therapeutics Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Antisense & RNAi Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Antisense & RNAi Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Antisense & RNAi Therapeutics Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Antisense & RNAi Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Antisense & RNAi Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Antisense & RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Antisense & RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Antisense & RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Antisense & RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Antisense & RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Antisense & RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Antisense & RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Antisense & RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Antisense & RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Antisense & RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Arbutus Biopharma (formerly known as Tekmira Pharmaceuticals) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Arbutus Biopharma (formerly known as Tekmira Pharmaceuticals) Product Profiles, Application and Specification

    • Table Arbutus Biopharma (formerly known as Tekmira Pharmaceuticals) Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Lorus Therapeutics (Aptose Biosciences) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Lorus Therapeutics (Aptose Biosciences) Product Profiles, Application and Specification

    • Table Lorus Therapeutics (Aptose Biosciences) Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table iCo Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table iCo Therapeutics Product Profiles, Application and Specification

    • Table iCo Therapeutics Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ionis Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ionis Pharmaceuticals Product Profiles, Application and Specification

    • Table Ionis Pharmaceuticals Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Calando Pharmaceuticals (Arrowhead Pharmaceuticals, Inc) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Calando Pharmaceuticals (Arrowhead Pharmaceuticals, Inc) Product Profiles, Application and Specification

    • Table Calando Pharmaceuticals (Arrowhead Pharmaceuticals, Inc) Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Acuitas Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Acuitas Therapeutics Product Profiles, Application and Specification

    • Table Acuitas Therapeutics Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Benitec Biopharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Benitec Biopharma Product Profiles, Application and Specification

    • Table Benitec Biopharma Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Olix Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Olix Pharmaceuticals Product Profiles, Application and Specification

    • Table Olix Pharmaceuticals Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Antisense Therapeutics Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Antisense Therapeutics Ltd Product Profiles, Application and Specification

    • Table Antisense Therapeutics Ltd Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi-Genzyme Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi-Genzyme Product Profiles, Application and Specification

    • Table Sanofi-Genzyme Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Gene Signal Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Gene Signal Product Profiles, Application and Specification

    • Table Gene Signal Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table miRagen Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table miRagen Therapeutics Product Profiles, Application and Specification

    • Table miRagen Therapeutics Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Rexahn Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Rexahn Pharmaceuticals Product Profiles, Application and Specification

    • Table Rexahn Pharmaceuticals Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline Plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Plc Product Profiles, Application and Specification

    • Table GlaxoSmithKline Plc Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Enzon Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Enzon Pharmaceuticals Inc Product Profiles, Application and Specification

    • Table Enzon Pharmaceuticals Inc Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Marina Biosciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Marina Biosciences Product Profiles, Application and Specification

    • Table Marina Biosciences Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Silence Therapeutics Plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Silence Therapeutics Plc Product Profiles, Application and Specification

    • Table Silence Therapeutics Plc Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Mirna Therapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Mirna Therapeutics Inc Product Profiles, Application and Specification

    • Table Mirna Therapeutics Inc Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Gradalis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Gradalis Product Profiles, Application and Specification

    • Table Gradalis Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Alnylam Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Alnylam Pharmaceuticals Product Profiles, Application and Specification

    • Table Alnylam Pharmaceuticals Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bio-Path Holdings Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bio-Path Holdings Inc Product Profiles, Application and Specification

    • Table Bio-Path Holdings Inc Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table OncoGeneX Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table OncoGeneX Pharmaceuticals Product Profiles, Application and Specification

    • Table OncoGeneX Pharmaceuticals Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Quark Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Quark Pharmaceuticals Product Profiles, Application and Specification

    • Table Quark Pharmaceuticals Antisense & RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US